|
|
||||||||
D. Mendelowitz was in the Department of Physiology, University of Tennessee, Memphis, TN 38163. Current address: Department of Pharmacology, George Washington University, 2300 Eye St., NW, Washington, DC 20037, USA.
| Abstract |
|---|
| Introduction |
|---|
|
|
|---|
When both parasympathetic and sympathetic activity are present, parasympathetic activity generally dominates. Increases in parasympathetic activity to the heart evoke a bradycardia that is more pronounced when there is a high level of sympathetic firing. When there is a moderate or high level of parasympathetic activity, changes in sympathetic firing elicit negligible changes in heart rate. There are a number of hypotheses concerning the mechanisms responsible for this interaction. The release of acetylcholine from parasympathetic neurons might act presynaptically to inhibit the release of norepinephrine from sympathetic nerve terminals. The parasympathetic-sympathetic interaction might also be the result of competition postsynaptically between different guanine nucleotide-binding (G) proteins within the membranes of sinoatrial pacemaker cells.
In many diseases, including hypertension and heart failure, cardiac vagal activity is diminished and unresponsive (14). The relative absence of cardiac vagal activity, or a diminished respiratory modulation of cardiac vagal activity, is often used clinically as an index of pathophysiology and the likelihood of sudden cardiac death. Restoration of cardiac vagal activity lessens ischemia and reperfusion-induced arrhythmias and decreases risk of sudden death after myocardial infarction, suggesting that increases in cardiac vagal activity could be an effective clinical target in heart diseases (13).
| Neurophysiology of cardiac vagal neurons |
|---|
|
|
|---|
The study of cardiac vagal activity in the central nervous system has been exceptionally difficult in vivo. This is caused by many factors, including the relatively small population of cardiac vagal neurons, experimental difficulties antidromically activating these neurons from their cardiac fibers projecting to the heart, and the location of their soma deep within the brain stem in a poorly defined and heterogeneous nucleus ambiguus. Furthermore, these studies have been hampered by the deleterious effects of the required surgical procedures, which include opening the chest, exposing the brain stem, anesthesia, and the difficulty of controlling the experimental conditions in these in vivo preparations.
More recent attempts at examination of cardiac vagal neurons, especially at the cellular level, have been greatly advanced with new methodological strategies including infrared visualization of neurons in in vitro brain stem slices coupled with the retention of physiological identity using retrograde fluorescent tracers. Using these techniques in this laboratory, we can visually identify and electrophysiologically manipulate cardiac vagal neurons with patch-clamp methodologies (6, 911).
Among the first hypotheses tested in this laboratory was whether cardiac vagal neurons in the rat possess pacemaker-like activity (6). The results, as illustrated in Fig. 1
, demonstrate that in the absence of synaptic activity, cardiac vagal neurons in the nucleus ambiguus are normally silent. Cardiac vagal neurons do not display any pacemaker-like activity such as repetitive or phasic depolarizations or action potentials. However, depolarizing currents (as little as 100 pA) are sufficient to evoke repetitive firing in cardiac vagal neurons. This activity occurs with little delay and minimal spike frequency adaptation during maintained depolarizing currents.
|
The absence of pacemaker activity in cardiac vagal neurons in vitro is consistent with the results from the rare successful in vivo studies. In such studies that have successfully identified and examined cardiac vagal neurons with extracellular electrodes, the great majority (identified by antidromic stimulation) were silent (5, 6). Only two cardiac vagal neurons have been recorded intracellularly in vivo, and these neurons were silent (6). The lack of ongoing cardiac vagal activity in these anesthetized in vivo animals is, at first, somewhat unexpected, because in conscious animals there is a high level of tonic cardiac vagal activity. However, in the in vivo experiments excitatory pathways to cardiac vagal neurons were likely inhibited because of the trauma of the acute open-chest surgery or anesthesia, which, in general, inhibits excitatory and augments inhibitory pathways. The tonic ongoing parasympathetic activity that is present in unanesthetized animals is therefore likely initiated, to a large extent, by an excitatory synaptic input that also appears susceptible to trauma and/or anesthesia.
One interpretation of the findings discussed above is that cardiac vagal neurons possess follower cell-like properties. Unlike other brain stem neurons, which may be involved in maintaining blood pressure or respiration in the absence of sensory information, such as those neurons in the nucleus tractus solitarii (NTS) that fire spontaneously even when impinging sensory synapses are silenced, or neurons in the pre-Botzinger complex that may have intrinsic respiratory rhythmogenic activity, the firing of cardiac vagal neurons is totally dependent on critical synaptic input to these neurons. The synaptic inputs to cardiac vagal neurons are therefore important in maintaining normal heart rates and cardiac function but seem to be easily silenced with stressful conditions, such as anesthesia or pain, consistent with the high heart rates and lack of respiratory sinus arrhythmia under these conditions.
| Synaptic innervation of cardiac vagal neurons from the NTS |
|---|
|
|
|---|
|
| Mechanisms responsible for generating cardiorespiratory interactions |
|---|
|
|
|---|
Although feedback from pulmonary stretch receptors and direct respiratory-related changes in venous return and cardiac stretch can evoke respiratory related fluctuations in heart rate, the dominant source of respiratory sinus arrhythmia originates from the brain stem (2). Respiratory sinus arrhythmia persists when the lungs are stationary (caused by muscle paralysis or constant flow ventilation), and the respiratory modulation of heart rate remains synchronized with brain stem respiratory rhythms even if artificial ventilation of the lungs, or chemoreceptor activation, occurs at different intervals. In animals, including humans, respiratory sinus arrhythmia is mediated via cardiac vagal activity. Respiratory sinus arrhythmia persists in experimental animals upon section of sympathetic pathways and in quadriplegic patients with spinal cord injury and sympathetic dysfunction.
The respiratory system also influences heart rate by modulating the baroreceptor and chemoreceptor input to cardiac vagal neurons. In animals, including humans, the baroreceptor and chemoreceptor reflexes are inhibited during inspiration and are facilitated during postinspiration and expiration or during a maintained phase of postinspiration and apnea (5). This respiratory modulation of both reflexes persists after pulmonary denervation, as well as ventilatory paralysis, suggesting that this "gating" of the baroreceptor and chemoreceptor reflexes also occurs within the brain stem.
Cardiac vagal neurons (recorded either at their soma in the nucleus ambiguus or from their axons in the vagus nerve) have pronounced respiratory modulation. Cardiac vagal neurons fire most rapidly in postinspiration and are often silent in inspiration and stage 2 expiration (5). However, the neurons and mechanisms within the central nervous system responsible for any type of cardiorespiratory interaction are largely unknown. Respiratory inputs do not alter baroreceptor neurons at either their soma or their presynaptic terminals. The presynaptic excitability of baroreceptor terminals in the NTS is not modified by the respiratory cycle, because baroreceptor-evoked postsynaptic responses in NTS neurons are unaltered by lung inflation or by stimulation of chemoreceptor fibers (8). The NTS neurons that receive synapses from baroreceptors also do not seem to be significantly modified by the respiratory cycle, because few, if any, NTS neurons receive converging input from baroreceptors and chemoreceptors. These observations indicate that respiratory modifications of the baroreceptor reflex do not occur early in the reflex pathway. Rather, the few data that exist suggest that cardiorespiratory interactions occur within the nucleus ambiguus.
| Central nervous system acetylcholine is likely involved in respiratory sinus arrhythmia |
|---|
|
|
|---|
|
-bungarotoxin (
Bgtx), indicating that these presynaptic receptors likely contain the
7 subunit of the nicotinic receptor (10). Nicotine also augments postsynaptic non-NMDA currents via a
Bgtx-insensitive receptor.
|
In summary, during the last 5 years there has been considerable progress in our understanding of the voltage-, Ca-, and ligand-gated channels, synaptic pathways, transmitters, and receptors involved in the central control of cardiac vagal activity. It is apparent that cardiac vagal neurons are inherently silent and depend on excitatory synaptic input for their activity. Synaptic inputs to cardiac vagal neurons include NTS neurons, which activate both NMDA and non-NMDA receptors in cardiac vagal neurons. It is also likely that postinspiratory cholinergic neurons activate postsynaptic nicotinic receptors and directly excite these neurons, which may be a mechanism responsible for respiratory sinus arrhythmia. Postinspiratory cholinergic neurons also likely activate presynaptic nicotinic receptors on glutamatergic terminals, which could facilitate, or gate, the baroreflex during postinspiration. However, much work is still needed, especially investigations concerning the presynaptic and postsynaptic receptors activated upon stimulation of identified synaptic pathways to cardiac vagal neurons and alterations in these receptors and channels during pathological disease states. It is hoped that a further understanding of the functional importance and pharmacological properties of presynaptic and postsynaptic receptors that determine cardiac vagal activity in the brain stem may allow us to identify agents that can reduce cardiac vagal activity in pathological conditions with abnormally low heart rates and cardiac function, such as SIDS, as well as increase vagal cardiac activity and reduce the fatality associated with cardiac hyperexcitability.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
V. C. Chitravanshi, S. Bhatt, and H. N. Sapru Microinjections of {alpha}-melanocyte stimulating hormone into the nucleus ambiguus of the rat elicit vagally mediated bradycardia Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2009; 296(5): R1402 - R1411. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Frank, H. S. Jameson, C. Gorini, and D. Mendelowitz Mapping and Identification of GABAergic Neurons in Transgenic Mice Projecting to Cardiac Vagal Neurons in the Nucleus Ambiguus Using Photo-Uncaging J Neurophysiol, April 1, 2009; 101(4): 1755 - 1760. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Toader, A. Cividjian, and L. Quintin Recruitment of cardiac parasympathetic activity: effects of clonidine on cardiac vagal motoneurones, pressure lability, and cardiac baroreflex slope in rats Br. J. Anaesth., March 1, 2009; 102(3): 322 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakamura, K. Kawabe, and H. N. Sapru Cardiovascular responses to microinjections of urocortin 3 into the nucleus tractus solitarius of the rat Am J Physiol Heart Circ Physiol, February 1, 2009; 296(2): H325 - H332. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang Nicotinic Receptors Partly Mediate Brainstem Autonomic Dysfunction Evoked by the Inhaled Anesthetic Isoflurane Anesth. Analg., January 1, 2009; 108(1): 134 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang Propofol and Isoflurane Enhancement of Tonic Gamma-Aminobutyric Acid Type A Current in Cardiac Vagal Neurons in the Nucleus Ambiguus Anesth. Analg., January 1, 2009; 108(1): 142 - 148. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakamura, K. Kawabe, and H. N. Sapru Cold pressor test in the rat: medullary and spinal pathways and neurotransmitters Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1780 - H1787. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Bailey, S. M. Appleyard, Y.-H. Jin, and M. C. Andresen Organization and Properties of GABAergic Neurons in Solitary Tract Nucleus (NTS) J Neurophysiol, April 1, 2008; 99(4): 1712 - 1722. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kamendi, O. Dergacheva, X. Wang, Z.-G. Huang, E. Bouairi, C. Gorini, and D. Mendelowitz NO Differentially Regulates Neurotransmission to Premotor Cardiac Vagal Neurons in the Nucleus Ambiguus Hypertension, December 1, 2006; 48(6): 1137 - 1142. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-G. Huang, K. J. S. Griffioen, X. Wang, O. Dergacheva, H. Kamendi, C. Gorini, E. Bouairi, and D. Mendelowitz Differential Control of Central Cardiorespiratory Interactions by Hypercapnia and the Effect of Prenatal Nicotine J. Neurosci., January 4, 2006; 26(1): 21 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A Smith, J. H Mitchell, and M. G Garry The mammalian exercise pressor reflex in health and disease Exp Physiol, January 1, 2006; 91(1): 89 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Dergacheva, X. Wang, Z.-G. Huang, E. Bouairi, C. Stephens, C. Gorini, and D. Mendelowitz Hypocretin-1 (Orexin-A) Facilitates Inhibitory and Diminishes Excitatory Synaptic Pathways to Cardiac Vagal Neurons in the Nucleus Ambiguus J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1322 - 1327. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Stiedl, M. Meyer, O. Jahn, S. O. Ogren, and J. Spiess Corticotropin-Releasing Factor Receptor 1 and Central Heart Rate Regulation in Mice during Expression of Conditioned Fear J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 905 - 916. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Neff, S. J. Simmens, C. Evans, and D. Mendelowitz Prenatal Nicotine Exposure Alters Central Cardiorespiratory Responses to Hypoxia in Rats: Implications for Sudden Infant Death Syndrome J. Neurosci., October 20, 2004; 24(42): 9261 - 9268. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-G. Huang, X. Wang, C. Evans, A. Gold, E. Bouairi, and D. Mendelowitz Prenatal Nicotine Exposure Alters the Types of Nicotinic Receptors That Facilitate Excitatory Inputs to Cardiac Vagal Neurons J Neurophysiol, October 1, 2004; 92(4): 2548 - 2554. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bouairi, R. Neff, C. Evans, A. Gold, M. C. Andresen, and D. Mendelowitz Respiratory sinus arrhythmia in freely moving and anesthetized rats J Appl Physiol, October 1, 2004; 97(4): 1431 - 1436. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Neff, J. Wang, S. Baxi, C. Evans, and D. Mendelowitz Respiratory Sinus Arrhythmia: Endogenous Activation of Nicotinic Receptors Mediates Respiratory Modulation of Brainstem Cardioinhibitory Parasympathetic Neurons Circ. Res., September 19, 2003; 93(6): 565 - 572. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Venkatesan, S. Baxi, C. Evans, R. Neff, X. Wang, and D. Mendelowitz Glycinergic Inputs to Cardiac Vagal Neurons in the Nucleus Ambiguus Are Inhibited by Nociceptin and {micro}-Selective Opioids J Neurophysiol, September 1, 2003; 90(3): 1581 - 1588. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, X. Wang, M. Irnaten, P. Venkatesan, C. Evans, S. Baxi, and D. Mendelowitz Endogenous Acetylcholine and Nicotine Activation Enhances GABAergic and Glycinergic Inputs to Cardiac Vagal Neurons J Neurophysiol, May 1, 2003; 89(5): 2473 - 2481. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Rentero, A. Cividjian, D. Trevaks, J. M. Pequignot, L. Quintin, and R. M. McAllen Activity patterns of cardiac vagal motoneurons in rat nucleus ambiguus Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2002; 283(6): R1327 - R1334. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Venkatesan, J. Wang, C. Evans, M. Irnaten, and D. Mendelowitz Nociceptin Inhibits gamma -Aminobutyric Acidergic Inputs to Cardiac Parasympathetic Neurons in the Nucleus Ambiguus J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 78 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. H. H. Leenen and B. Yuan Mortality After Coronary Artery Occlusion in Different Models of Cardiac Hypertrophy in Rats Hypertension, February 1, 2001; 37(2): 209 - 215. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Irnaten, R. A. Neff, J. Wang, A. D. Loewy, T. C. Mettenleiter, and D. Mendelowitz Activity of Cardiorespiratory Networks Revealed by Transsynaptic Virus Expressing GFP J Neurophysiol, January 1, 2001; 85(1): 435 - 438. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dhar, F. Nagy, J. M. McIntosh, and H. N. Sapru Receptor subtypes mediating depressor responses to microinjections of nicotine into medial NTS of the rat Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2000; 279(1): R132 - R140. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |